Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 19 May 2022 for Teva Pharmaceutical Industries Ltd, €1.0M. Read the official filing
Filing timeline
BuySaleHafrun Fridriksdottir
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Hafrun Fridriksdottir: trading record in brief
Hafrun Fridriksdottir, listed as senior executive, appears in our data through filings on Teva Pharmaceutical Industries Ltd shares, published by SEC (Form 4). We count 6 filings; the first trade dates from 11 May 2021 and the latest from 17 May 2022.
Every open-market trade on record is a sale: 2 sales worth €1.4M. Outside the open market, there are 4 option exercises. Since January 2022: no purchases and 1 sale on the market.
Most recently, on 19 May 2022, the filings show an open-market sale worth €1.0M in Teva Pharmaceutical Industries Ltd. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hafrun Fridriksdottir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
130,000 shares@ US$8.21590.0028% mcap54.0% of flowOrdinary SharesSEC:0001209191-22-030308:0
51,488 sharesOrdinary SharesSEC:0001209191-22-017046:0
21,682 sharesOrdinary SharesSEC:0001209191-22-014469:0
16,121 sharesOrdinary SharesSEC:0001209191-22-008415:0
50,860 shares@ US$9.949329.9% of flowOrdinary SharesSEC:0001209191-21-051075:0
37,884 sharesOrdinary SharesSEC:0001209191-21-032252:0
6 of 6 declarations
